Other alternatives in the “Biotech” equity space include SPDR S&P Biotech (NYSEArca: XBI), First Trust Amex Biotechnology (NYSEArca: FBT), PowerShares Dynamic Biotechnology & Genome (NYSEArca: PBE), and Market Vectors Biotech (NYSEArca: BBH).
From the leveraged side, ProShares Ultra Nasdaq Biotechnology (NasdaqGM: BIB) delivers two times the daily leveraged exposure to the same index that IBB tracks, and conversely, ProShares UltraShort Nasdaq Biotechnology (NYSEArca: BIS) caters to those looking for daily short exposure to the index.
From a performance standpoint, FBT has led the pack year to date, having rallied 29.94%, with BBH coming in a close second, up 27.12%. XBI and PBE are up 18.51% and 4.94% respectively, and IBB falls somewhere in the middle of the pack up 15.38%.
iShares Nasdaq Biotechnology
For more information on Street One ETF research and ETF trade execution/liquidity services, contact [email protected].
